TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma.

Andrew X Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.